Keragon
Healthcare Software · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
177 Huntington Ave Ste 1703, Boston, Mas...Website
www.keragon.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
2
1
1
1
About Keragon
Keragon is a privately held healthcare automation platform founded in 2022 by George Eracleous and headquartered in Boston, United States. The company specializes in connecting various healthcare software systems to build HIPAA-compliant automations without the need for coding, aiming to streamline workflows and enhance efficiency in healthcare operations. In February 2025, Keragon secured a $7.5 million seed funding round, bringing its total funding to $10.5 million.Explore more
Keragon Org Chart
AB
Automation Specialist
WC
Automation Specialist
JT
Automation Specialist
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Keragon your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Keragon recently announced quarterly report
Click to see if Keragon had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Keragon
Check if Keragon has recently received funding, and reach out quickly before it becomes old news!
Keragon, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Keragon is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Keragon launches new products
Funding: Get notified immidiatlly once Keragon has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Keragon
Compare insights from companies similar to Keragon, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Keragon is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Keragon is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Keragon.
Keragon financials insights
Gather financial insights about Keragon, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Other Financing Round
$3M
2025
Angel/Seed
$7.5M
Keragon Tech Stack
A closer look at the technologies used by Keragon
See more technologies
Keragon News & Media
Keragon AI turns plain English into HIPAA-compliant healthcare automation
NEW YORK, Feb. 12, 2026 /PRNewswire/ -- Keragon, the leading healthcare automation platform, today announced the launch of Keragon AI, which transforms how administrative and clinical operations teams build and deploy HIPAA-compliant automations. As the industry's first plain-English...
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Keragon
Sign Up For FreeTo access detailed company insights
Keragon is a privately held healthcare automation platform founded in 2022 by George Eracleous and headquartered in Boston, United States. The company specializes in connecting various healthcare software systems to build HIPAA-compliant automations without the need for coding, aiming to streamline workflows and enhance efficiency in healthcare ope... Read More
